Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14567603rdf:typepubmed:Citationlld:pubmed
pubmed-article:14567603lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C1140621lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0010280lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C1861172lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0443254lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C1705994lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0456904lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C0441988lld:lifeskim
pubmed-article:14567603lifeskim:mentionsumls-concept:C1513492lld:lifeskim
pubmed-article:14567603pubmed:issue4lld:pubmed
pubmed-article:14567603pubmed:dateCreated2003-10-21lld:pubmed
pubmed-article:14567603pubmed:abstractTextEvidence-based reviews support the use of venous thromboembolism (VTE) prophylaxis in the form of compression devices and/or stockings for patients undergoing craniotomy. In patients undergoing craniotomy with motor mapping for glioma, the contralateral lower extremity should remain visible so that motor responses can be accurately identified. As a consequence, these patients could be placed at a higher risk to develop VTE. The authors have quantified the incidence of VTE in patients undergoing craniotomy with motor mapping and have shown that there is no increased risk of developing a VTE in the contralateral lower extremity when compression devices are not used.lld:pubmed
pubmed-article:14567603pubmed:languageenglld:pubmed
pubmed-article:14567603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567603pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14567603pubmed:statusMEDLINElld:pubmed
pubmed-article:14567603pubmed:monthOctlld:pubmed
pubmed-article:14567603pubmed:issn0022-3085lld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:LambornKathle...lld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:BergerMitchel...lld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:ZadaGabrielGlld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:Quinones-Hino...lld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:AugusteKurtis...lld:pubmed
pubmed-article:14567603pubmed:authorpubmed-author:GadkaryChirag...lld:pubmed
pubmed-article:14567603pubmed:issnTypePrintlld:pubmed
pubmed-article:14567603pubmed:volume99lld:pubmed
pubmed-article:14567603pubmed:ownerNLMlld:pubmed
pubmed-article:14567603pubmed:authorsCompleteYlld:pubmed
pubmed-article:14567603pubmed:pagination680-4lld:pubmed
pubmed-article:14567603pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:meshHeadingpubmed-meshheading:14567603...lld:pubmed
pubmed-article:14567603pubmed:year2003lld:pubmed
pubmed-article:14567603pubmed:articleTitleIncidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg.lld:pubmed
pubmed-article:14567603pubmed:affiliationDepartment of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco School of Medicine, San Francisco, California 94143-0112, USA.lld:pubmed
pubmed-article:14567603pubmed:publicationTypeJournal Articlelld:pubmed